3-iodobenzylguanidine has been researched along with dacarbazine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, J; Iwaoka, T; Naomi, S; Oishi, S; Sasaki, M; Sato, T; Tokunaga, H; Umeda, T; Yamauchi, J | 1 |
| Hosoi, S; Itoh, H; Kojima, M; Minamikawa, T; Ukimura, O; Watanabe, H | 1 |
| Kopf, D; Lehnert, H; Mundschenk, J | 1 |
| Shapiro, B; Shulkin, BL; Sisson, JC; Spaulding, S; Urba, S; Zempel, S | 1 |
| Berthold, F; Gahr, M; Hero, B; Hunneman, DH | 1 |
| Naruse, M; Takano, K; Tanabe, A; Tsuiki, M | 1 |
| Dralle, H; Eisenhofer, G; Lehnert, H; Pacak, K; Scholz, T | 1 |
| Bodoky, G; Pregun, I; Rácz, K; Tulassay, Z | 1 |
| Basu, EM; Cheung, NK; Kramer, K; Kushner, BH; Modak, S; Roberts, SS | 1 |
| Gotoh, M; Kato, M; Kobayashi, H; Matsukawa, Y; Yamamoto, T; Yamauchi, Y; Yoshino, Y | 1 |
| Del Rivero, J; Ilanchezhian, M; Jha, A; Pacak, K | 1 |
4 review(s) available for 3-iodobenzylguanidine and dacarbazine
| Article | Year |
|---|---|
[Malignant pheochromocytoma].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Catecholamines; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Diagnosis, Differential; Diagnostic Imaging; Germ-Line Mutation; Humans; Iodine Radioisotopes; Pheochromocytoma; Prognosis; Radiopharmaceuticals; Succinate Dehydrogenase; Vincristine | 2006 |
Clinical review: Current treatment of malignant pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Humans; Iodine Radioisotopes; Pheochromocytoma; Vincristine | 2007 |
[Carcinoid tumors].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biomarkers, Tumor; Bronchial Neoplasms; Carcinoid Tumor; Chromogranin A; Clinical Trials as Topic; Dacarbazine; Early Detection of Cancer; Gastrointestinal Neoplasms; Heterocyclic Compounds; Humans; Hydroxyindoleacetic Acid; Lung Neoplasms; Organometallic Compounds; Prevalence; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Somatostatin; Temozolomide; Thalidomide; TOR Serine-Threonine Kinases; Treatment Outcome | 2010 |
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Cytoreduction Surgical Procedures; Dacarbazine; Everolimus; Humans; Liver Neoplasms; Lung Neoplasms; Octreotide; Paraganglioma; Pheochromocytoma; Poly(ADP-ribose) Polymerase Inhibitors; Radiopharmaceuticals; Surgical Procedures, Operative; Vincristine | 2020 |
3 trial(s) available for 3-iodobenzylguanidine and dacarbazine
| Article | Year |
|---|---|
[Therapy of malignant pheochromocytoma. Invitation to participate in a randomized multicenter study].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Dacarbazine; Drug Therapy, Combination; Humans; Indium Radioisotopes; Injections, Subcutaneous; Interferon-alpha; Iodine Radioisotopes; Octreotide; Pheochromocytoma; Placebos; Radionuclide Imaging; Radiopharmaceuticals; Time Factors; Vincristine | 1998 |
Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Female; Humans; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Vincristine | 1999 |
Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Examination; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Homovanillic Acid; Humans; Ifosfamide; Iodine Radioisotopes; Life Tables; Melphalan; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vanilmandelic Acid; Vincristine; Vindesine | 2001 |
4 other study(ies) available for 3-iodobenzylguanidine and dacarbazine
| Article | Year |
|---|---|
A case of Sipple's syndrome with malignant pheochromocytoma treated with 131I-metaiodobenzyl guanidine and a combined chemotherapy with cyclophosphamide, vincristine and dacarbazine.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Multiple Endocrine Neoplasia Type 2a; Pheochromocytoma; Vincristine | 1994 |
[A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and CVD regimen].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Pheochromocytoma; Vincristine | 1994 |
5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Irinotecan; Male; Neuroblastoma; Outpatients; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Temozolomide | 2013 |
[A CASE OF MALIGNANT PARAGANGLIOMA OF THE URINARY BLADDER TREATED WITH CYCLOPHOSPHAMIDE, VINCRISTINE, AND DACARBAZINE CHEMOTHERAPY AND METAIODOBENZYLGUANIDINE THERAPY].
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cystectomy; Dacarbazine; Disease-Free Survival; Humans; Iodine Radioisotopes; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Paraganglioma; Radiopharmaceuticals; Radiotherapy; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Diversion; Vincristine | 2018 |